Stéphanie Eid1,2, Suzan Boutary1, Kawthar Braych1, Ramzi Sabra3, Charbel Massaad2, Ahmed Hamdy4, Awad Rashid4, Sarah Moodad1, Karen Block5, Yves Gorin5, Hanna E Abboud5, Assaad A Eid1. 1. 1 Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine and Medical Center, American University of Beirut , Beirut, Lebanon . 2. 2 UMR-S 1124 INSERM, Paris Descartes University, Sorbonne Paris Cite University , Centre Interdisciplinaire Chimie Biology, Paris, France . 3. 3 Department of Pharmacology and Toxicology, Faculty of Medicine and Medical Center, American University of Beirut , Beirut, Lebanon . 4. 4 Department of Nephrology, Hamad Medical Corporation , Doha, Qatar . 5. 5 Department of Medicine, South Texas Veterans Healthcare System and the University of Texas Health Science Center , San Antonio, Texas.
Abstract
AIM: Podocyte apoptosis is a critical mechanism for excessive loss of urinary albumin that eventuates in kidney fibrosis. Oxidative stress plays a critical role in hyperglycemia-induced glomerular injury. We explored the hypothesis that mammalian target of rapamycin complex 2 (mTORC2) mediates podocyte injury in diabetes. RESULTS: High glucose (HG)-induced podocyte injury reflected by alterations in the slit diaphragm protein podocin and podocyte depletion/apoptosis. This was paralleled by activation of the Rictor/mTORC2/Akt pathway. HG also increased the levels of Nox4 and NADPH oxidase activity. Inhibition of mTORC2 using small interfering RNA (siRNA)-targeting Rictor in vitro decreased HG-induced Nox1 and Nox4, NADPH oxidase activity, restored podocin levels, and reduced podocyte depletion/apoptosis. Inhibition of mTORC2 had no effect on mammalian target of rapamycin complex 1 (mTORC1) activation, described by our group to be increased in diabetes, suggesting that the mTORC2 activation by HG could mediate podocyte injury independently of mTORC1. In isolated glomeruli of OVE26 mice, there was a similar activation of the Rictor/mTORC2/Akt signaling pathway with increase in Nox4 and NADPH oxidase activity. Inhibition of mTORC2 using antisense oligonucleotides targeting Rictor restored podocin levels, reduced podocyte depletion/apoptosis, and attenuated glomerular injury and albuminuria. INNOVATION: Our data provide evidence for a novel function of mTORC2 in NADPH oxidase-derived reactive oxygen species generation and podocyte apoptosis that contributes to urinary albumin excretion in type 1 diabetes. CONCLUSION: mTORC2 and/or NADPH oxidase inhibition may represent a therapeutic modality for diabetic kidney disease. Antioxid. Redox Signal. 25, 703-719.
AIM: Podocyte apoptosis is a critical mechanism for excessive loss of urinary albumin that eventuates in kidney fibrosis. Oxidative stress plays a critical role in hyperglycemia-induced glomerular injury. We explored the hypothesis that mammalian target of rapamycin complex 2 (mTORC2) mediates podocyte injury in diabetes. RESULTS: High glucose (HG)-induced podocyte injury reflected by alterations in the slit diaphragm protein podocin and podocyte depletion/apoptosis. This was paralleled by activation of the Rictor/mTORC2/Akt pathway. HG also increased the levels of Nox4 and NADPH oxidase activity. Inhibition of mTORC2 using small interfering RNA (siRNA)-targeting Rictor in vitro decreased HG-induced Nox1 and Nox4, NADPH oxidase activity, restored podocin levels, and reduced podocyte depletion/apoptosis. Inhibition of mTORC2 had no effect on mammalian target of rapamycin complex 1 (mTORC1) activation, described by our group to be increased in diabetes, suggesting that the mTORC2 activation by HG could mediate podocyte injury independently of mTORC1. In isolated glomeruli of OVE26 mice, there was a similar activation of the Rictor/mTORC2/Akt signaling pathway with increase in Nox4 and NADPH oxidase activity. Inhibition of mTORC2 using antisense oligonucleotides targeting Rictor restored podocin levels, reduced podocyte depletion/apoptosis, and attenuated glomerular injury and albuminuria. INNOVATION: Our data provide evidence for a novel function of mTORC2 in NADPH oxidase-derived reactive oxygen species generation and podocyte apoptosis that contributes to urinary albumin excretion in type 1 diabetes. CONCLUSION:mTORC2 and/or NADPH oxidase inhibition may represent a therapeutic modality for diabetic kidney disease. Antioxid. Redox Signal. 25, 703-719.
Entities:
Keywords:
NADPH oxidases; diabetic nephropathy; mTORC2; reactive oxygen species
Authors: S Eid; W Abou-Kheir; R Sabra; G Daoud; A Jaffa; F N Ziyadeh; L Roman; A A Eid Journal: J Biol Regul Homeost Agents Date: 2013 Jul-Sep Impact factor: 1.711
Authors: Dmitry A Goncharov; Tatiana V Kudryashova; Houman Ziai; Kaori Ihida-Stansbury; Horace DeLisser; Vera P Krymskaya; Rubin M Tuder; Steven M Kawut; Elena A Goncharova Journal: Circulation Date: 2013-11-22 Impact factor: 29.690
Authors: Mohamed Noureldein; Rashad Nawfal; Sara Bitar; Scott S Maxwell; Ishant Khurana; Hala Kfoury Kassouf; Fadlo R Khuri; Assam El-Osta; Assaad A Eid Journal: Cell Mol Life Sci Date: 2022-08-30 Impact factor: 9.207
Authors: Rayan Bou-Fakhredin; Batoul Dia; Hilda E Ghadieh; Stefano Rivella; Maria Domenica Cappellini; Assaad A Eid; Ali T Taher Journal: Int J Mol Sci Date: 2021-01-23 Impact factor: 5.923
Authors: William S Azar; Rachel Njeim; Angie H Fares; Nadim S Azar; Sami T Azar; Mazen El Sayed; Assaad A Eid Journal: Rev Endocr Metab Disord Date: 2020-12 Impact factor: 9.306